Literature DB >> 19832872

Ano-perianal tuberculosis: 15 years of clinical experiences in Southern Taiwan.

W-C Tai1, T-H Hu, C-H Lee, H-H Chen, C-C Huang, S-K Chuah.   

Abstract

OBJECTIVE: Ano-perianal tuberculosis (TB) is a rare extrapulmonary form of the disease. Most publications are in case report form. We report our cohort retrospective study on ano-perianal TB, which is one of the very few original reports in the literature.
METHOD: Over a period of 15 years (January 1992-December 2006), file records revealed cases with confirmed diagnosis of ano-perianal TB after screening from a total of 1251 patients with the diagnosis of TB from Chang Gung Memorial Hospital-Kaohsiung, Taiwan.
RESULTS: This study recruited 17 patients (14 male patients and 3 female patients). The age ranged from 18 to 81 years with a mean age of 44.8 +/- 18.2 years. Thirteen patients had coexistent pulmonary TB (76.5%). Eight patients had at least one concomitant co-morbid illness (47.1%). The most common clinical manifestations were anal fistulae (n = 16). All patients who completed a full course of anti-mycobacterial treatment for at least 6 months after surgical intervention were cured without recurrence except for one patient who was lost to follow-up after 2 months of treatment. Seven of the nine patients with complicated fistulae needed longer anti-mycobacterium treatment duration (9-18 months).
CONCLUSION: Ano-perianal TB should be kept in mind for all patients with prolonged or repeatedly recurrent ano-perianal symptoms and signs such as complicated fistulae in an endemic TB area like Taiwan. Management strategy is with conventional anti-mycobacterium therapy for at least 6 months after surgery. An extension of the anti-mycobacterium treatment course to 9-18 months is mandatory for patients with complicated disease presentations.

Entities:  

Mesh:

Year:  2009        PMID: 19832872     DOI: 10.1111/j.1463-1318.2009.02057.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

1.  Tuberculosis: a perennial pain in the posterior?

Authors:  Guang H Yim; Douglas M Bowley; Martin J Dedicoat; Mark S Bailey
Journal:  Int J Colorectal Dis       Date:  2014-11-06       Impact factor: 2.571

2.  Perianal Tuberculosis.

Authors:  Henry Tan Chor Lip; Tan Jih Huei; Ng Zi Qin
Journal:  J Gastrointest Surg       Date:  2021-01-29       Impact factor: 3.452

3.  Anal tuberculosis complicating anti-TNFα therapy.

Authors:  Nuria Luquín; Mar Masiá; Raúl Noguera; Félix Gutiérrez
Journal:  BMJ Case Rep       Date:  2014-11-24

4.  Perianal tuberculosis: A case report and review of the literature.

Authors:  Sayaka Tago; Yuji Hirai; Yusuke Ainoda; Takahiro Fujita; Mikio Takamori; Ken Kikuchi
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

Review 5.  Perianal infections: a primer for nonsurgeons.

Authors:  Masood Mansour; Lynn A Weston
Journal:  Curr Gastroenterol Rep       Date:  2010-08

6.  Diagnosis of anorectal tuberculosis by polymerase chain reaction, GeneXpert and histopathology in 1336 samples in 776 anal fistula patients.

Authors:  Pankaj Garg; Ankita Goyal; Vipul D Yagnik; Sushil Dawka; Geetha R Menon
Journal:  World J Gastrointest Surg       Date:  2021-04-27

7.  Exceptional dissemination of perineal tuberculosis up to the right flank: a tribute to J.P. Nesselrod's study on the anatomy of pelvic lymphatics published in 1936 in the Annals of Surgery.

Authors:  X Huber; E Bernasconi; S Tschuor-Costa; R Rosso
Journal:  Int J Colorectal Dis       Date:  2013-01-19       Impact factor: 2.571

8.  Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan.

Authors:  Wei-Chen Tai; Chien-Hua Chiu; Chih-Ming Liang; Kuo-Chin Chang; Chung-Mou Kuo; Yi-Chun Chiu; Keng-Liang Wu; Ming-Luen Hu; Yeh-Pin Chou; Shue-Shian Chiou; King-Wah Chiu; Chung-Huang Kuo; Tsung-Hui Hu; Ming-Tsung Lin; Seng-Kee Chuah
Journal:  Gastroenterol Res Pract       Date:  2013-10-22       Impact factor: 2.260

Review 9.  Quinolone-containing therapies in the eradication of Helicobacter pylori.

Authors:  Seng-Kee Chuah; Wei-Chen Tai; Chen-Hsiang Lee; Chih-Ming Liang; Tsung-Hui Hu
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.